Patents by Inventor Stefan Petry

Stefan Petry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
    Patent number: 8148395
    Abstract: The present invention relates to azolopyridin-3-one derivatives of the general formula I with the meanings indicated in the description, their pharmaceutically usable salts and their use as medicinal substances.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: April 3, 2012
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Muller, Norbert Tennagels
  • Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors
    Patent number: 8008331
    Abstract: The invention relates to benzothiazol-2-one derivatives of general formula (I) with the meanings indicated in the description, the pharmaceutically usable salts thereof, and the use thereof as medicinal substances.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: August 30, 2011
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Müller, Hubert Heuer, Norbert Tennagels
  • Indazole derivatives as inhibitors of hormone sensitive lipase
    Patent number: 7968719
    Abstract: The present invention relates to indazole derivatives of the general formulae I or II having the meanings indicated in the description, to the pharmaceutically useful salts thereof and the use thereof as drugs.
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: June 28, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Muller, Hubert Heuer, Karl-Heinz Baringhaus
  • CARBAMOYLBENZOTRIAZOLE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
    Publication number: 20110118321
    Abstract: The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
    Type: Application
    Filed: January 20, 2011
    Publication date: May 19, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Stefan PETRY, Gerhard ZOLLER, Norbert TENNAGELS, Günter Müller
  • Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases
    Patent number: 7897616
    Abstract: The present invention relates to imidazopyridin-2-one derivatives of the formula I with the definitions specified in the description, to their pharmaceutically usable salts and to their use as medicaments.
    Type: Grant
    Filed: September 22, 2008
    Date of Patent: March 1, 2011
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Markus Follmann, Gunter Muller, Norbert Tennagels
  • Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
    Patent number: 7897625
    Abstract: The invention relates to carbamoylbenzotriazole derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: March 1, 2011
    Assignee: Sanofi-Aventis
    Inventors: Stefan Petry, Gerhard Zoller, Norbert Tennagels, Günter Müller
  • AZOLOPYRIDIN-2-ONE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHIBITORS
    Publication number: 20110039883
    Abstract: The present invention provides compounds which have an inhibitory effect on hormone-sensitive lipase or endothelial lipase. The compounds of the invention are azolopyridin-2-one derivatives of the general formula I wherein the substituents are as defined herein. The compounds of formula I wherein R2 is hydrogen are distinguished by favorable effects on disorders of lipid metabolism. They beneficially influence the HDL to LDL ratio and increase in particular the HDL level and are suitable for the prevention and treatment of dyslipidemias and metabolic syndrome and their diverse sequelae such as atherosclerosis, coronary heart disease, heart failure, obesity and diabetes. The compounds of formula I wherein R1 and R2 together form a ring system are distinguished by favorable effects on metabolic disorders.
    Type: Application
    Filed: October 28, 2010
    Publication date: February 17, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Müller, Hubert Heuer, Norbert Tennagels
  • Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors
    Patent number: 7846943
    Abstract: The present invention provides compounds which have an inhibitory effect on hormone-sensitive lipase or endothelial lipase. The compounds of the invention are azolopyridin-2-one derivatives of the general formula I wherein the substituents are as defined herein. The compounds of formula I wherein R2 is hydrogen are distinguished by favorable effects on disorders of lipid metabolism. They beneficially influence the HDL to LDL ratio and increase in particular the HDL level and are suitable for the prevention and treatment of dyslipidemias and metabolic syndrome and their diverse sequelae such as atherosclerosis, coronary heart disease, heart failure, obesity and diabetes. The compounds of formula I wherein R1 and R2 together form a ring system are distinguished by favorable effects on metabolic disorders.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: December 7, 2010
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Müller, Hubert Heuer, Norbert Tennagels
  • Diacyl indazole derivatives as lipase and phospholipase inhibitors
    Publication number: 20100286133
    Abstract: The invention relates to diacyl indazole derivatives of general formulae (I) or (II) and to the pharmaceutically acceptable salts thereof: Wherein X, R1 and R2 are as defined herein. The invention also relates to the use of these compounds as pharmaceutical products.
    Type: Application
    Filed: July 20, 2010
    Publication date: November 11, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Gerhard ZOLLER, Stefan PETRY, Gunter MÜLLER, Hubert HEUER, Norbert TENNAGELS
  • Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments
    Patent number: 7781613
    Abstract: Disclosed are compounds of the general formula (I), with the definitions of the substituents R1 to R5, A and X being detailed in the text, and to their physiologically tolerated salts, to processes for preparing these compounds and to the use thereof as inhibitors of hormone-sensitive lipase (HSL).
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: August 24, 2010
    Assignee: Sanofi-Aventis
    Inventors: Karl Schoenafinger, Stefan Petry, Guenter Mueller, Karl-Heinz Baringhaus
  • Diacyl indazole derivatives as lipase and phospholipase inhibitors
    Patent number: 7772268
    Abstract: The invention relates to diacyl indazole derivatives of general formulae (I) or (II) and to the pharmaceutically acceptable salts thereof: Wherein X, R1 and R2 are as defined herein. The invention also relates to the use of these compounds to treat diabetes mellitus, dyslipidemia and atherosclerotic disorders.
    Type: Grant
    Filed: April 8, 2008
    Date of Patent: August 10, 2010
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Müller, Hubert Heuer, Norbert Tennagels
  • TRIAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
    Publication number: 20100190801
    Abstract: The invention relates to triazolopyridine derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
    Type: Application
    Filed: March 25, 2010
    Publication date: July 29, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Stefan PETRY, Gerhard ZOLLER, Günter MÜLLER, Karl-Heinz BARINGHAUS, Hubert HEUER
  • BENZOOXAZOL-2-ONE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHIBITORS
    Publication number: 20100173961
    Abstract: The invention relates to benzooxazol-2-one derivatives of general formula (I) with the meanings indicated in the description, the pharmaceutically usable salts thereof, and the use thereof as medicinal substances.
    Type: Application
    Filed: March 18, 2010
    Publication date: July 8, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Gerhard ZOLLER, Stefan PETRY, Gunter MÜLLER, Hubert HEUER, Norbert TENNAGELS
  • Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes
    Patent number: 7741491
    Abstract: The invention therefore relates to compounds of the formula I in which the variables are as defined in the specification, to pharmaceutical compositions containing them and to their use for therapeutically lowering blood glucose levels.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: June 22, 2010
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Stefan Petry, Karl-Heinz Baringhaus, Norbert Tennangels, Guenter Mueller, Reinhard Kirsch
  • 5-Oxoisoxazoles as inhibitors of lipases and phospholipases
    Publication number: 20100152246
    Abstract: The present invention relates to 5-oxoisoxazole derivatives of the formula I, the pharmaceutically usable salts thereof and the use thereof as medicinal substances.
    Type: Application
    Filed: October 5, 2009
    Publication date: June 17, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Stefan PETRY, Manfred SEIDEL, Gerhard ZOLLER, Gunter MÜLLER, Karl-Heinz BARINGHAUS, Hubert HEUER
  • Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing them and their use
    Patent number: 7737144
    Abstract: The invention relates to pyrimido[5,4-e][1,2,4]triazine-5,7-diones, pharmaceutically acceptable salts thereof and physiologically functional derivatives. The invention therefore relates to compounds of the formula I, in which the radicals have the given meanings, and to their physiologically tolerated salts and processes for preparing them. The compounds are suitable for use as antidiabetics, for example.
    Type: Grant
    Filed: June 28, 2007
    Date of Patent: June 15, 2010
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Stefan Petry, Karl-Heinz Baringhaus, Norbert Tennagels, Guenter Mueller
  • Triazolopyridine derivatives as inhibitors of lipases and phospholipases
    Patent number: 7718669
    Abstract: The invention relates to triazolopyridine derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.
    Type: Grant
    Filed: April 9, 2008
    Date of Patent: May 18, 2010
    Assignee: Sanofi-Aventis
    Inventors: Stefan Petry, Gerhard Zoller, Günter Müller, Karl-Heinz Baringhaus, Hubert Heuer
  • Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors
    Patent number: 7709513
    Abstract: The invention relates to benzooxazol-2-one derivatives of general formula (I) with the meanings indicated in the description, the pharmaceutically usable salts thereof, and the use thereof as medicinal substances.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: May 4, 2010
    Assignee: Sanofi-Aventis
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Müller, Hubert Heuer, Norbert Tennagels
  • IMIDAZOLIDINE CARBOXAMIDE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHIBITORS
    Publication number: 20100105719
    Abstract: The present invention relates to imidazolidinecarboxamide derivatives of the general formula I, wherein R, R1, R2, X and Y are as defined herein, or pharmaceutically usable salts thereof and the use thereof as medicinal substances.
    Type: Application
    Filed: October 2, 2009
    Publication date: April 29, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Gerhard ZOLLER, Stefan PETRY, Gunter MÜLLER, Norbert TENNAGELS
  • INDAZOLE DERIVATIVES AS INHIBITORS OF HORMONE SENSITIVE LIPASE
    Publication number: 20090215824
    Abstract: The present invention relates to indazole derivatives of the general formulae I or II having the meanings indicated in the description, to the pharmaceutically useful salts thereof and the use thereof as drugs.
    Type: Application
    Filed: April 28, 2009
    Publication date: August 27, 2009
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Gerhard Zoller, Stefan Petry, Gunter Muller, Hubert Heuer, Karl-Heinz Baringhaus